This site is intended for health professionals only

Covid-19

P2Y12 inhibitor add-on to heparin of no benefit in non-critically ill COVID-19 patients
Casirivimab and imdevimab reduce incidence of symptomatic COVID-19
Casirivimab and imdevimab reduce incidence of symptomatic COVID-19
Booster COVID-19 vaccination increases immune response in cancer patients on active treatment
Booster COVID-19 vaccination increases immune response in cancer patients on active treatment
Vaccination associated with a smaller reduction in transmission of the Delta variant than Alpha form
Vaccination associated with a smaller reduction in transmission of the Delta variant than Alpha form
Atorvastatin comparable to placebo for COVID-19 patients in ICU
Atorvastatin comparable to placebo for COVID-19 patients in ICU
Cross-reactive T cells protect against COVID-19 infection
Cross-reactive T cells protect against COVID-19 infection
Point-of-care COVID-19 test in the ED reduces turnaround-time
Point-of-care COVID-19 test in the ED reduces turnaround-time
Third COVID-19 vaccine dose only 37% effective against Omicron after 7 days
Third COVID-19 vaccine dose only 37% effective against Omicron after 7 days
Immunosuppressive biologics not associated with increased risk of COVID-19 or mortality
Immunosuppressive biologics not associated with increased risk of COVID-19 or mortality
Molnupiravir therapy leads to 50% lower hospitalisation in unvaccinated COVID-19 patients
Molnupiravir therapy leads to 50% lower hospitalisation in unvaccinated COVID-19 patients
Sickle cell disease patients’ heightened awareness of COVID-19 risks reduced cases
Sickle cell disease patients’ heightened awareness of COVID-19 risks reduced cases
RNA aptamer binding to COVID-19 spike protein prevents cellular entry
RNA aptamer binding to COVID-19 spike protein prevents cellular entry
1 2 3 … 21


Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Merck agrees huge Vioxx settlement
4
Janssen-Cilag’s Stelara approved by NICE
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe